Therapeutic Implications of Drug Interactions in the Treatment of Human Immunodeficiency Virus-Related Tuberculosis

• Published in: Clinical infectious diseases 1999-03, Vol.28 (3), p.419-430
• Main Authors: Burman, William J., Gallicano, Keith, Peloquin, Charles
• Format: Article
• Language: English
• Subjects: AIDS; Antacids; Anti-HIV Agents - pharmacokinetics; Anti-HIV Agents - therapeutic use; Antibiotics, Antitubercular - pharmacokinetics; Antibiotics, Antitubercular - therapeutic use; Antitubercular Agents - pharmacokinetics; Antitubercular Agents - therapeutic use; Antituberculars; Antivirals; Biological and medical sciences; Dosage; Drug Interactions; Drug toxicity and drugs side effects treatment; HIV; HIV Infections - complications; HIV Infections - drug therapy; HIV Infections - metabolism; HIV Protease Inhibitors - pharmacokinetics; HIV Protease Inhibitors - therapeutic use; Humans; Medical sciences; Miscellaneous (drug allergy, mutagens, teratogens...); Pharmacokinetics; Pharmacology. Drug treatments; Protease inhibitors; Reverse Transcriptase Inhibitors - pharmacokinetics; Reverse Transcriptase Inhibitors - therapeutic use; Rifamycins - pharmacokinetics; Rifamycins - therapeutic use; State-of-the-Art Clinical Article; Tuberculosis; Tuberculosis - complications; Tuberculosis - drug therapy; Tuberculosis - metabolism
• ISSN: 1058-4838; 1537-6591
• DOI: 10.1086/515174

Abstract only